Kentucky Retirement Systems Insurance Trust Fund Has $428,000 Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Kentucky Retirement Systems Insurance Trust Fund lessened its position in shares of Revvity, Inc. (NYSE:RVTY) by 7.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,073 shares of the company’s stock after selling 323 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Revvity were worth $428,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Price T Rowe Associates Inc. MD lifted its stake in shares of Revvity by 1.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 168,547 shares of the company’s stock valued at $17,698,000 after acquiring an additional 2,153 shares during the period. Magnetar Financial LLC grew its position in shares of Revvity by 441.3% in the 1st quarter. Magnetar Financial LLC now owns 136,371 shares of the company’s stock valued at $14,319,000 after purchasing an additional 111,178 shares during the period. Quadrature Capital Ltd acquired a new position in shares of Revvity in the 1st quarter valued at approximately $1,267,000. EntryPoint Capital LLC acquired a new position in shares of Revvity in the 1st quarter valued at approximately $48,000. Finally, MQS Management LLC acquired a new position in shares of Revvity in the 1st quarter valued at approximately $236,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Trading Up 6.5 %

RVTY traded up $7.46 during trading hours on Monday, reaching $122.61. The company’s stock had a trading volume of 842,038 shares, compared to its average volume of 868,811. The stock has a market cap of $15.13 billion, a PE ratio of 100.92, a P/E/G ratio of 3.00 and a beta of 1.05. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.23 and a quick ratio of 1.92. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $127.88. The business’s 50-day moving average is $108.82 and its 200-day moving average is $106.46.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, July 29th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. The firm had revenue of $691.70 million for the quarter, compared to analyst estimates of $690.33 million. Revvity had a net margin of 5.49% and a return on equity of 7.37%. Revvity’s revenue was down 2.5% compared to the same quarter last year. During the same quarter last year, the business earned $1.21 earnings per share. As a group, equities research analysts predict that Revvity, Inc. will post 4.64 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 18th will be given a $0.07 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.23%. Revvity’s dividend payout ratio is currently 23.14%.

Insider Transactions at Revvity

In other news, insider Joel S. Goldberg sold 4,000 shares of the company’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $110.46, for a total transaction of $441,840.00. Following the transaction, the insider now owns 36,900 shares in the company, valued at $4,075,974. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on RVTY. Robert W. Baird boosted their price objective on Revvity from $126.00 to $127.00 and gave the company an “outperform” rating in a research report on Tuesday, April 30th. Barclays dropped their price target on Revvity from $116.00 to $115.00 and set an “equal weight” rating on the stock in a research note on Friday, June 28th. TD Cowen upped their price objective on Revvity from $123.00 to $130.00 and gave the company a “buy” rating in a report on Tuesday, April 30th. Leerink Partnrs raised Revvity to a “strong-buy” rating in a report on Monday, July 8th. Finally, Jefferies Financial Group started coverage on Revvity in a research note on Monday, June 3rd. They issued a “hold” rating and a $115.00 price objective on the stock. Seven investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $119.14.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.